OrthoPediatrics (NASDAQ:KIDS) Stock Price Down 3.5% on Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS) traded down 3.5% on Wednesday after an insider sold shares in the company. The company traded as low as $24.48 and last traded at $24.54. 22,235 shares changed hands during trading, a decline of 86% from the average session volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of the business’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $133,224.74. Following the sale, the insider now owns 148,788 shares of the company’s stock, valued at approximately $3,698,869.68. The trade was a 3.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Fred Hite sold 6,443 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $160,172.98. Following the sale, the chief financial officer now directly owns 207,989 shares in the company, valued at approximately $5,170,606.54. The trade was a 3.00 % decrease in their position. The disclosure for this sale can be found here. In other OrthoPediatrics news, CEO David R. Bailey sold 6,620 shares of the business’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the sale, the chief executive officer now owns 319,155 shares of the company’s stock, valued at approximately $7,934,193.30. The trade was a 2.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on KIDS shares. Stifel Nicolaus lowered their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 5th. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday, March 5th. Finally, Truist Financial decreased their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th.

OrthoPediatrics Stock Performance

The company’s 50 day moving average price is $24.79 and its 200-day moving average price is $25.53. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The company has a market cap of $596.44 million, a PE ratio of -19.95 and a beta of 1.22.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million during the quarter, compared to analyst estimates of $51.16 million. During the same quarter last year, the business posted ($0.23) EPS. Equities research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. AWM Investment Company Inc. grew its stake in OrthoPediatrics by 14.8% in the 4th quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock valued at $11,979,000 after buying an additional 66,779 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in OrthoPediatrics by 76.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 19,863 shares of the company’s stock valued at $460,000 after buying an additional 8,631 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in OrthoPediatrics in the 4th quarter valued at approximately $7,450,000. Numerai GP LLC bought a new position in OrthoPediatrics in the 4th quarter valued at $372,000. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in OrthoPediatrics by 25.5% in the 4th quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,292 shares of the company’s stock valued at $1,513,000 after purchasing an additional 13,270 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.